January 8, 2024 — GE HealthCare announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, ho

January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra AV2 and

Diagnostic and Interventional Cardiology

As the Diagnostic and Interventional Cardiology (DAIC) team welcomes in the New Year, we also have taken a few moments to reflect back on the Top 10 most read content from 2023.

1. A Dietary Supplement Leads to Remarkable Regression in Atherosclerotic Lesions

January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden useability and applicability for patients, today announced that a record number five patients were successfully treated at a single center on the same day with the ZETA Balloon Expandable Aortic Valve System to treat aortic valve disease.

January 4, 2024 — The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of evidence grows to allow patients to eat before the procedure.

Patients undergoing coronary artery catheterization are typically required to take nothing by mouth after midnight prior to their procedure, but there is no evidence to support this long-standing practice.

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart Disease team show that severe mitral stenosis, due to a build-up of calcium deposits in the mitral valve common in elderly patients, can be safely and successfully treated using Intravascular lithotripsy (IVL)-enabled percutaneous balloon mitral valvuloplasty. However, larger prospective studies in high-risk population are needed to confirm the findings.

January 4, 2024 — Artificial Intelligence (AI)-driven Primary Care company K Health has announced it has entered into a know-how agreement with Mayo Clinic to tackle the prevention and care of heart-related conditions.

January 3, 2024 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and STOP-ADHF pilot studies.

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care solutions, today announced that it has surpassed 250,000 patients receiving a HeartFlow FFRCT Analysis.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now